ArticleEBioMedicine2016
Precision Medicine: The new era in medicine.
Article in EBioMedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Digital twin for personalized medicine development.Frontiers in digital health · 2025Review
- Comparison of Metabolic Syndrome, Autoimmune and Viral Distinctive Inflammatory Related Conditions as Affected by Body Mass Index.Journal of clinical medicine · 2024Article
- Deep learning in bioinformatics.Turkish journal of biology = Turk biyoloji dergisi · 2023Article
- Investigating acceptability of a training programme in precision medicine for frontline healthcare professionals: a mixed methods study.BMC medical education · 2022Review
- The advanced development of molecular targeted therapy for hepatocellular carcinoma.Cancer biology & medicine · 2022Review
- MMKP: A mind mapping knowledgebase prototyping tool for precision medicine.Frontiers in immunology · 2022Article
- The Need of Personalized Medicine in Coping with Stress during Infertility Treatment.Journal of personalized medicine · 2021Article
- THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.Life sciences, society and policy · 2020Review
- Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines.Frontiers in cellular and infection microbiology · 2020Article
- Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-γ and aspirin.Acta biomaterialia · 2020Article
- Advancing challenges in Paediatric Virology: An interview with Professor Barbara A. Rath, Co-founder and Chair of the Vienna Vaccine Safety Initiative.Experimental and therapeutic medicine · 2019Article
- Prevalence of clinically actionable genotypes and medication exposure of older adults in the community.Pharmacogenomics and personalized medicine · 2017Article
- Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.Drug safety · 2016Article
- Male Infertility, Precision Medicine and Systems Proteomics.Journal of reproduction & infertilityReview
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.